Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
The iconic Budweiser Clydesdales will no longer have their tails shortened using a common, yet controversial, procedure that has drawn the ire of animal activists, parent company Anheuser-Busch InBev announced Wednesday.
The Federal Reserve left its key interest rate unchanged Wednesday for the second time in its past three meetings, a sign that it’s moderating its fight against inflation as price pressures have eased. But Fed officials also signaled that they expect to raise rates once more this year.